Deciphering the molecular mechanism responsible for G6PD expression regulation, i.e., finding the transcription factor(s) mediating RIP140 effects in ER+ and ER− breast cancers, requires further investigations, and could improve our knowledge of transcriptional control of the PPP. The gene discussed is G6PD; the disease is breast carcinoma.